Substance use and cognition in early psychosis

Journal of Psychiatry and Neuroscience

Volumn 28, Issue 1, 2003, Pages 48-54

  Pencer, Alissa ^a   Addington, Jean ^b,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Age of onset; Alcohol drinking; Cannabis; Cognition disorders; Psychotic disorders; Schizophrenia; Substance related disorders

Indexed keywords

ALCOHOL; CANNABIS; CENTRAL STIMULANT AGENT; COCAINE; PSYCHEDELIC AGENT;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL FEATURE; COGNITION; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; OUTPATIENT CARE; PATHOGENESIS; PSYCHOSIS; RATING SCALE; SUBSTANCE ABUSE; TIME SERIES ANALYSIS;

ADOLESCENT; ADULT; COGNITION DISORDERS; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; PSYCHOSES, SUBSTANCE-INDUCED; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 0037221559     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Cantwell R, Brewin J, Glazebrook C, Dalkin T, Fox R, Medley I, et al. Prevalence of substance misuse in first-episode psychosis. Br J Psychiatry 1999;174:150-3.
2. Strakowski SM, Mauricio T, Stoll AL, Faedda G, Mayer PV, Kolbrener ML, et al. Comorbidity in psychosis at first hospitalization. Am J Psychiatry 1993;150:752-7.
3. Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry 1991;48:224-30.
4. Drake RE, Osher FC, Wallach MA. Alcohol use and abuse in schizophrenia. J Nerv Ment Dis 1989;177:408-14.
5. Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 1994;51:273-9.
6. Bartels SJ, Teague GB, Drake RE, Clark RE, Bush PW, Noordsy DL. Substance abuse in schizophrenia: service utilization and costs. J Nerv Ment Dis 1993;181:227-32.
7. Seibyl JP, Satel SL, Anthony D, Southwick SM, Krystal JH, Charney DS. Effects of cocaine on hospital course in schizophrenia. J Nerv Ment Dis 1993;181:31-7.
8. Swofford CD, Scheller-Gilkey G, Miller AH, Woolwine B, Mance R. Double jeopardy: schizophrenia and substance use. Am J Drug Alcohol Abuse 2000;26:343-53.
9. Pristach CA, Smith CM. Medication compliance and substance abuse among schizophrenic patients. Hosp Community Psychiatry 1990;41:1345-8.
10. Arndt S, Tyrrel G, Flaum M, Andreasen NC. Comorbidity of substance abuse and schizophrenia: the role of premorbid adjustment. Psychol Med 1992;22:379-88.
11. Addington J, Addington D. Substance abuse and cognitive functioning in schizophrenia. J Psychiatry Neurosci 1997;22:99-104.
12. Beatty WW, Katzung VM, Moreland VJ, Nixon SJ. Neuropsychological performance of recently abstinent alcoholics and cocaine abusers. Drug Alcohol Depend 1995;37:247-53.
13. Hoff AL, Riordan H, Morris L, Cestaro V, Wieneke M, Alpert R, et al. Effects of crack cocaine on neurocognitive function. Psychiatry Res 1996;60:167-76.
14. Loberg T. Neuropsychological findings in early and middle phases of alcoholism. In: Grant I, Adams K, editors. Neuropsychological assessment of neuropsychiatric disorders. New York: Oxford University Press; 1986. p. 415-40.
15. O'Malley S, Adamse M, Heaton, RK, Gawin FH. Neuropsychological impairment in chronic cocaine abusers. Am J Drug Alcohol Abuse 1992;18:131-44.
16. Pope HG, Gruber AJ, Yurgelun-Todd D. The residual neuropsychological effects of cannabis: the current status of research. Drug Alcohol Depend 1995;38:25-34.
17. Hoff AL, Riordan H, O'Donnell DW, Morris L, DeLisi LE. Neuropsychological functioning of first-episode schizophreniform patients. Am J Psychiatry 1992;149:898-903.
18. Saykin AJ, Gur BC, Gur RE, Mozley D, Mozley, LH, Resnick SM, et al. Neuropsychological function in schizophrenia: selective impairment in memory and learning. Arch Gen Psychiatry 1991;48:618-24.
19. Cleghorn JM, Kaplan RD, Szechtman B, Szechtman H, Brown GM, Franco S. Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function. J Clin Psychiatry 1991;52:26-30.
20. Nixon SJ, Hallford HG, Tivis RD. Neurocognitive function in alcoholic, schizophrenic, and dually diagnosed patients. Psychiatry Res 1996;64:35-45.
21. Serper MR, Bergman A, Copersino ML, Chou J-CY, Richarme D, Canero R. Learning and memory impairment in cocaine dependant and comorbid schizophrenic patients. Psychiatry Res 2000;93:387-94.
22. Sevy S, Kay SR, Opler L, van Praag HM. Significance of cocaine history in schizophrenia. J Nerv Ment Dis 1990;178:642-8.
23. Cooper L, Liberman D, Tucker D, Nuechterlein KH, Tsuang J, Barnett HL. Neurocognitive deficits in the dually diagnosed with schizophrenia and cocaine abuse. Psychiatr Rehab Skills 1999;3:231-45.
24. Addington J, el-Guebaly N. Group treatment for substance abuse in schizophrenia. Can J Psychiatry 1998;43:843-5.
25. Addington J, Duchak V. Reasons for substance use in schizophrenia. Acta Psych Scand 1997;96:329-33.
26. Mueser KT, Bellack AS, Blanchard JJ. Comorbidity of schizophrenia and substance abuse: implications for treatment. J Consult Clin Psychology 1992;60:845-56.
27. Negrete JC, Knapp WP, Douglas DE, Smith WB. Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey. Psychol Med 1986;16:515-20.
28. Addington J, Addington D. Early intervention for psychosis: the Calgary Early Psychosis Treatment & Prevention Program. Can Psychiat Assoc Bull 2001;33:11-6.
29. Larsen TK, McGlashan TH, Moe LC. First-episode schizophrenia: I. Early course parameters. Schizophr Bull 1996;22:241-56.
30. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): American Psychiatric Association; 1994.
31. Spitzer RL, Williams JB, Gibbon M, First MB. The structured clinical interview for DSM-W SCID. I. History, rationale, and description. Arch Gen Psychiatry 1992;49:624-9.
32. Kay SR, Fizbein A, Opler LA. The Positive and Negative Syndrome Scale PANSS for Schizophrenia. Schizophr Bull 1987;13:261-76.
33. Drake RE, Osher FC, Noordsy DL, Hurlbut SC, Teague GB, Beaudett MS. Diagnosis of alcohol use disorders in schizophrenia. Schizophr Bull 1990;16:57-67.
34. Drake RE, McHugo GJ, Noordsy DL. Treatment of alcoholism among schizophrenic outpatients: 4-year outcomes. Am J Psychiatry 1993;150:328-9.
35. Drake RE, Osher FC, Noordsy DL, Hurlbut SC, Teague GB, Beaudett MS. Diagnosis of alcohol use disorders in schizophrenia. Schizophr Bull 1990;16:57-67.
36. Nuechterlein KH. Vigilance in schizophrenia and related disorders. In: Steinhauer SR, Gruzelier JH, Zubin J, editors. Handbook of schizophrenia. Vol. 5. Neuropsychology, psychophysiology and information processing. Amsterdam: Elsevier Science; 1991. p. 397-433.
37. Nuechterlein KH, Asarnow RF. UCLA Continuous Performance Test [manual and computer program]. Version 4. Los Angeles: University of California, Los Angeles; 1992.
38. Asarnow RF, Granholm E, Sherman T. Span of apprehension in schizophrenia. In: Steinhauer SR, Gruzelier JH, Zubin J, editors. Handbook of schizophrenia. Vol. 5. Neuropsychology, psychophysiology and information processing. Amsterdam: Elsevier Science; 1991. p. 335-70.
39. Asarnow RF, Nuechterlein KH. UCLA Forced-Choice Span of Apprehension Test [manual and computer program]. Version 4. Los Angeles: University of California, Los Angeles; 1992.
40. Addington J, Addington D. Cognitive functioning in first-episode schizophrenia. J Psychiatry Neurosci 2002;27:188-92.
41. Mueser KT, Bellack AS, Blanchard JJ. Comorbidity of schizophrenia and substance abuse: implications for treatment. J Consult Clin Psychol 1992;60:845-56.
42. Eckhardt MJ, Stapleton JM, Rawlings RR, Davis EZ, Grondin DM. Neuropsychological functioning in detoxified alcoholics between 18 and 35 years of age. Am J Psychiatry 1995;153:53-9.
43. Addington J, Addington D. Intervention strategies for substance use in early psychosis. J Psychiatr Rehab 2001;25:60-7.
44. Tracy JI, Josiassen R, Bellack AS. Neuropsychology of dual diagnosis: understanding the combined effects of schizophrenia and substance use disorders. Clin Psychol Rev 1995;15:67-97.
45. Wolthaus JE, Dingemans PM, Schene AH, Linszen DH. Cannabis abuse, symptoms and personality traits in recent-onset schizophrenia [abstract]. Schizophr Res 2001;49:9.
46. Klegon DA, Fiedosewicz H, Chang HH, Bayog CR, Berman I. Clinical significance of substance abuse in patients with schizophrenia [abstract]. Schizophr Res 2001;49:36.